Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Pharmacogenomics J. 2015 Jul 7;16(1):10–17. doi: 10.1038/tpj.2015.44

Table 3.

Results of meta-analysis for smoking cessation based on adjusted data

Source Sample size Odds ratio 95% CI Weight Weight (%)
Sabol et al. 1999 (cancer risk) 104 3.28 1.10–9.78 3.22 1.15
Sabol et al. 1999 (personality genetics) 127 1.55 0.75–3.20 7.33 2.62
Sabol et al. 1999 (sexual behavior) 283 1.46 0.91–2.34 17.23 6.15
Jorm et al. 2000 409 1.16 0.79–1.72 25.47 9.09
Vandenbergh et al. 2002 (adjusted data) 251 0.81 0.46–1.41 12.41 4.43
Lerman et al. 2003 418 1.16 0.79–1.70 26.01 9.28
O’Gara et al. 2007 563 1.16 0.83–1.62 34.07 12.16
Swan et al. 2007 323 0.81 0.51–1.30 17.84 6.37
Ton et al. 2007 554 1.37 0.90–2.07 22.2 7.92
David et al. 2007 295 1.26 0.78–2.04 16.41 5.86
Styn et al. 2009 (adjusted data) 864 1.04 0.76–1.42 40.23 14.26
Tashkin et al. 2012 621 1.29 0.94–1.77 38.42 13.71
Gordiev et al. 2013 364 1.10 0.71–1.72 19.36 6.91
Pooled analysis 5176 1.17 1.04–1.31 280.1 100

Notes: Test for heterogeneity: X2 =10.46, d.f. =12 (P = 0.58), I2 = 0%. Test for overall effect under both fixed-effects and random-effects model: Z = 2.62 (P = 0.009).